Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196358 Method and kit to profile tumors by biomarker analyses including transcriptional factor assays
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196356 Tumour Growth Inhibitory Compounds and Methods of their Use
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196352 Composition for increasing stamina
08/05/2010US20100196350 Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
08/05/2010US20100196342 Mood, memory and cognitive function with pyridoxal 5'-phosphate
08/05/2010US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level
08/05/2010US20100196325 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
08/05/2010US20100196321 Compounds
08/05/2010US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/2010US20100196316 Cyclosporin analogues for preventing or treating hepatitis c infection
08/05/2010US20100196308 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010US20100196305 Sulfone polymer compositions
08/05/2010US20100196286 Inhalation delivery methods and devices
08/05/2010US20100196281 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196277 Nanoparticle compositions for controlled delivery of nucleic acids
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010US20100192945 Inhalation devices and related methods for administration of sedative hypnotic compounds
08/05/2010DE10247073B4 Verfahren zur Herstellung von monomeren Uronsäuren, insbesondere D-Mannuronsäure und D-Guluronsäure und deren Verwendung als Arzneimittel Process for the preparation of monomeric uronic acids, in particular D-mannuronic acid and D-guluronic acid, and their use as medicaments
08/05/2010DE102009007152A1 Ultrasound gel, useful in ultrasonic diagnosis, phlebology, pediatrics and tattoo and piercing studios, comprises mondamin, octenisept, lidocaine and carbostesin
08/05/2010DE102009006602A1 Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010CA2787429A1 A high molecular weight polysaccharide that binds and inhibits virus
08/05/2010CA2758599A1 Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
08/05/2010CA2751285A1 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
08/05/2010CA2751275A1 Methods for improving cognitive function and decreasing heart rate
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2751236A1 Finely pulverized pharmaceutical composition
08/05/2010CA2751215A1 Cell lines expressing cftr and methods of using them
08/05/2010CA2751176A1 Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/05/2010CA2751125A1 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010CA2751068A1 Anti-cancer protein-platinum conjugates
08/05/2010CA2751054A1 Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/05/2010CA2751037A1 Drug abuse deterrent, methods and compositions
08/05/2010CA2751033A1 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/05/2010CA2750944A1 Compositions and methods for the treatment of cancer
08/05/2010CA2750928A1 Methods of diagnosing and treating neurodegenerative diseases
08/05/2010CA2750865A1 Cosmetic composition containing ketogluconic acid derivatives
08/05/2010CA2750835A1 Carboxamide compounds and methods for using the same
08/05/2010CA2750801A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010CA2750798A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010CA2750796A1 5-ht4 inhibitors for treating airway diseases, in particular asthma
08/05/2010CA2750769A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
08/05/2010CA2750758A1 Treatment of psoriasis
08/05/2010CA2750742A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/05/2010CA2750710A1 Fused ring compound and use thereof
08/05/2010CA2750686A1 Composition comprising caftaric acid and/or derivatives thereof
08/05/2010CA2750685A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010CA2750659A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010CA2750565A1 Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010CA2750245A1 Polynucleotide aptamer-based cross-linked materials and uses thereof
08/05/2010CA2750219A1 Transdermal delivery of diclofenac, carbamazepine and benzydamine
08/05/2010CA2750188A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/05/2010CA2750059A1 Coated tablets of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine and methods for measuring effectiveness of coating
08/05/2010CA2750045A1 Bridged compounds as hiv integrase inhibitors
08/05/2010CA2749947A1 Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
08/05/2010CA2749943A1 Preservation of ergothioneine
08/05/2010CA2749884A1 Bicyclic pyrazolo-heterocycles
08/05/2010CA2749746A1 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
08/05/2010CA2749533A1 Solid oral formulations of a pyridopyrimidinone
08/05/2010CA2749531A1 Galenic formulations of organic compounds
08/05/2010CA2749397A1 Pharmaceutical compositions comprising phosphate-binding polymer
08/05/2010CA2749204A1 Methods to treat cancer
08/05/2010CA2748847A1 Anti-inflammatory macrolide
08/05/2010CA2747961A1 Piperidine derivatives as nk3 receptor antagonists
08/05/2010CA2747396A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/05/2010CA2746967A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/04/2010EP2213750A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213738A2 siRNA molecules targeting Bcl-2
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213736A2 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness
08/04/2010EP2213679A1 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
08/04/2010EP2213675A1 Pyridooxazepine derivative and use thereof
08/04/2010EP2213674A1 Purification method of pemetrexed salts,sodium salts and disodium salts
08/04/2010EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
08/04/2010EP2213670A2 Epothilone derivatives
08/04/2010EP2213669A1 Crystalline imidazol-5-carboxylic acid derivate
08/04/2010EP2213667A1 Cephalomannine derivatives and their preparation, medicinal composition and use
08/04/2010EP2213666A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
08/04/2010EP2213665A1 Erlotinib hydrochloride
08/04/2010EP2213664A1 Process for the preparation of cyclopenta[g]quinazoline derivatives
08/04/2010EP2213661A1 c-Met Modulators and Methods of Use
08/04/2010EP2213660A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof
08/04/2010EP2213655A1 Methods For Purifying Aminoalkyl Tetracycline Compounds
08/04/2010EP2213652A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
08/04/2010EP2213650A1 Substituted diphenylamines as inhibitors of reverse transcriptase, process of preparing them and use thereof
08/04/2010EP2213309A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent
08/04/2010EP2213308A1 Eyedrop comprising agar
08/04/2010EP2213305A1 Method for producing granulated matter
08/04/2010EP2213304A1 Granule, tablet, and their production methods
08/04/2010EP2213303A1 Pharmaceutical composition for treatment of cataract
08/04/2010EP2213300A1 Composition and method for treating cancer using herpes virus
08/04/2010EP2213294A1 Use of compositions comprising tricin
08/04/2010EP2213293A2 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers
1 ... 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 ... 7860